Are you Dr. Shah?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 69 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1275 York Ave
Department Of Medicine
New York, NY 10065Phone+1 212-639-2282
Summary
- Dr. Gaurav Shah, MD is an oncologist in New York, New York. He is currently licensed to practice medicine in New York.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2005 - 2008
Brigham and Women's HospitalResidency, Internal Medicine, 2001 - 2004
Columbia University Vagelos College of Physicians and SurgeonsClass of 2001
Certifications & Licensure
NY State Medical License 2004 - 2025
Publications & Presentations
PubMed
- 149 citationsComparison of linear and volumetric criteria in assessing tumor response in adult high-grade gliomas.Gaurav D. Shah, Santosh Kesari, Ronghui Xu, Tracy T. Batchelor, Alison O’Neill
Neuro-Oncology. 2006-01-01 - 424 citationsOlaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trialWilliam D. Tap, Robin L. Jones, Brian A. Van Tine, Bartosz Chmielowski, Anthony D. Elias
Lancet. 2016-07-30 - 572 citationsEverolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, place...John J. Bissler, J. Christopher Kingswood, Elżbieta Radzikowska, Bernard A. Zonnenberg, Michael Frost
Lancet. 2013-03-09
Press Mentions
Rocket Pharmaceuticals to Present at William Blair Biotech Focus ConferenceJuly 8th, 2022- Rocket Pharmaceuticals to Present at UBS Global Healthcare ConferenceMay 11th, 2022
- Rocket Pharmaceuticals Names Chief HR OfficerSeptember 7th, 2021
- Join now to see all
